New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.

Children who experience multiple cases of dengue virus develop an army of dengue-fighting T cells, according to a new study ...

Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma ...

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb ...

Two therapeutic "cocktails" could stop immune cells from overreacting to allergens, providing long-lasting asthma relief.

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...

Scientists at La Jolla Institute for Immunology (LJI) are advancing a new kind of therapy. According to a recent study published in the Journal of Allergy and Clinical Immunology, their approach ...